Serum uric acid and renal function in patients with type 1 diabetes: a nationwide study in Brazil

被引:4
作者
Pizarro, Marcela Haas [1 ]
Santos, Deborah Conte [1 ]
Vasconcelos Barros, Bianca Senger [1 ]
Nunes de Melo, Laura Gomes [2 ]
Gomes, Marilia Brito [1 ]
机构
[1] State Univ Rio de Janeiro UERJ, Diabet Unit, Dept Internal Med, Rio De Janeiro, RJ, Brazil
[2] State Univ Rio de Janeiro UERJ, Dept Ophthalmol, Rio De Janeiro, RJ, Brazil
来源
DIABETOLOGY & METABOLIC SYNDROME | 2018年 / 10卷
关键词
Type; 1; diabetes; Serum uric acid; Glomerular filtration rate; Chronic renal disease; Albuminuria; CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; GLYCEMIC CONTROL; NEPHROPATHY; ALLOPURINOL; RISK; HYPERURICEMIA; HYPERTENSION; PROGRESSION; MORTALITY;
D O I
10.1186/s13098-018-0324-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Diabetes nephropathy is a microvascular complication associated with high morbidity and mortality in patients with type 1 diabetes, and its pathogenesis is not fully understood. Our aim was to evaluate the association between levels of serum uric acid and renal function assessed by glomerular filtration rate (GFR) and albuminuria in patients with type 1 diabetes. Methods: This is a multicenter, cross-sectional, observational study with 1686 patients, conducted between August 2011 and August 2014 in 14 public clinics from ten Brazilian cities. Renal function was estimated by CKD-EPI (adults) and by Schwartz (adolescents). Results: We analyzed 1686 patients, aged 30.1 +/- 12.0, with 15.4 +/- 9.3 years of duration of diabetes; 55.8% were female and 54.0% were Caucasians. Serum uric acid was related to renal function, with a mean of 4.8 +/- 1.4 (in the normal renal function group) vs 5.2 +/- 2.0 (GFR >= 60 ml/min and albuminuria) vs 6.5 +/- 2.6 mg/dl (GFR < 60 ml/min). In the pooled group, multivariate analysis showed an inverse correlation between serum uric acid and GFR (r = -0.316, p < 0.001) with a decrease of 4.11 ml/min in the GFR for every increase of 1 mg/dl in serum uric acid. Considering only patients with normal renal function (n = 1170), a decrease of 2.04 ml/min in the GFR for every increase of 1 mg/dl in Serum uric acid was noted using multivariate analysis. Conclusions: Patients with higher levels of serum uric acid have worse renal function, independently of HbA1c or duration of diabetes, which persisted even in patients with normal renal function. Further prospective studies are necessary to establish if patients with higher serum uric acid may have an elevated risk for developing chronic kidney disease.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Effect Ramadan fasting on renal function in patients with type 2
    Abushady, M. M.
    Samy, M.
    Bekhet, M.
    Abdullah, A.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 153 : 176 - 183
  • [32] The correlation between serum uric acid and diabetic kidney disease in type 1 diabetes patients in Anhui, China
    Jiang, Jun
    Zhou, Xiaowan
    Lan, Lei
    Ren, Wei
    BMC NEPHROLOGY, 2023, 24 (01)
  • [33] Epidemiology of diabetic kidney disease in adult patients with type 1 diabetes in Italy: The AMD-Annals initiative
    Pacilli, Antonio
    Viazzi, Francesca
    Fioretto, Paola
    Giorda, Carlo
    Ceriello, Antonio
    Genovese, Stefano
    Russo, Giuseppina
    Guida, Pietro
    Pontremoli, Roberto
    De Cosmo, Salvatore
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2017, 33 (04)
  • [34] A Study on Serum Uric Acid Level in Type II Diabetes Mellitus
    Samin, Kashif Ali
    Ullah, Khalil
    Shah, Muhammad Ikram
    Ansari, Abidamateen
    Khalil, Sadia
    Saeed, Maryam
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2021, 15 (07): : 2317 - 2319
  • [35] Economic status and clinical care in young type 1 diabetes patients: a nationwide multicenter study in Brazil
    Gomes, Marilia B.
    de Mattos Matheus, Alessandra Saldanha
    Calliari, Luis Eduardo
    Luescher, Jorge Luiz
    Della Manna, Thais
    Savoldelli, Roberta Diaz
    Cobas, Roberta A.
    Coelho, Wellington Siqueira
    Tschiedel, Balduino
    Ramos, Alberto Jose
    Fonseca, Reine Marie
    Araujo, Neuza Braga C.
    Almeida, Henriqueta Guido
    Melo, Naira Horta
    Jezini, Debora Laredo
    Negrato, Carlos Antonio
    ACTA DIABETOLOGICA, 2013, 50 (05) : 743 - 752
  • [36] Correlation Between Serum Uric Acid Level and Central Body Fat Distribution in Patients with Type 2 Diabetes
    Zong, Jing
    Sun, Yi
    Zhang, Yiqian
    Yuan, Jin
    Wang, Xinlei
    Zhang, Rongping
    Zhao, Xiaoqin
    Zhao, Xuying
    Gu, Yunjuan
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2020, 13 : 2521 - 2531
  • [37] Serum uric acid level is associated with metabolic syndrome and microalbuminuria in Korean patients with type 2 diabetes mellitus
    Kim, Eun Sook
    Kwon, Hyuk Sang
    Ahn, Chul Woo
    Lim, Dong Jun
    Shin, Jeong Ah
    Lee, Seung Hwan
    Cho, Jae Hyoung
    Yoon, Kun Ho
    Kang, Moo Il
    Cha, Bong Yun
    Son, Ho Young
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2011, 25 (05) : 309 - 313
  • [38] Uric Acid Lowering to Prevent Kidney Function Loss in Diabetes: The Preventing Early Renal Function Loss (PERL) Allopurinol Study
    Maahs, David M.
    Caramori, Luiza
    Cherney, David Z. I.
    Galecki, Andrzej T.
    Gao, Chuanyun
    Jalal, Diana
    Perkins, Bruce A.
    Pop-Busui, Rodica
    Rossing, Peter
    Mauer, Michael
    Doria, Alessandro
    CURRENT DIABETES REPORTS, 2013, 13 (04) : 550 - 559
  • [39] Changes in albuminuria and renal outcome in patients with type 2 diabetes and hypertension: a real-life observational study
    Viazzi, Francesca
    Ceriello, Antonio
    Fioretto, Paola
    Giorda, Carlo
    Guida, Pietro
    Russo, Giuseppina
    Greco, Eulalia
    De Cosmo, Salvatore
    Pontremoli, Roberto
    JOURNAL OF HYPERTENSION, 2018, 36 (08) : 1719 - 1728
  • [40] Serum Uric Acid Level as a Harbinger of Type 2 Diabetes: A Prospective Observation in Taiwan
    Wu, Wen-Chih
    Lai, Yen-Wen
    Chou, Yu-Ching
    Liao, Yu-Chan
    You, San-Lin
    Bai, Chyi-Huey
    Sun, Chien-An
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, 17 (07)